Luisa Schmidt, PhD student in the group of Florian Grebien has received a prestigious DOC fellowship from the Austrian Academy of Sciences. She studies the contribution of the transcription factor C/EBPα to acute myeloid leukemia and is particularly interested in how disease development is influenced by the epigenomic landscape and super-enhancers. Her project aims to elucidate the molecular functions of the leukemia-associated, truncated isoform C/EBPα p30 by exploring its influence on the epigenome.
The Ludwig Boltzmann Gesellschaft (LBG) invited with Prof. Dr. Gerard Evan (Head of Department of Biochemistry, University of Cambridge, UK) (chair), Prof. Dr. Aly Karsan (Department of Pathology and Laboratory Medicine, University of British Columbia; Medical Director, Centre for Clinical Genomics, Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada) Prof. Dr.
Every year, on 4 February, the World Health Organisation (WHO) promotes ways to ease the global burden of cancer.
Prof. Lukas Kenner has been appointed as member of the Research Advisory Committee of Prostate Cancer UK. In this position he will advise the Board of Trustees and Chief Executive of the Charity on its research strategies and policies, and to make recommendations as to which research grants the charity should support.
An entire decade of exciting research at the LBI-CR has passed since the institute was founded in September 2005. We generated significant research output as measured by publications, attraction of third party money, and seeing former members successfully embarking on international careers. This achievement was celebrated in November 2015 with a scientific meeting, which brought together some outstanding researchers, who have contributed to the success of the institute with their advice, support or collaboration.
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins in November 2015.
Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) is a focused effort to develop protective and therapeutic HIV vaccines bringing together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA, including the LBI-CR.
Prof. Emilio Casanova, Prof. Lukas Kenner and Prof. Richard Moriggl gave their inaugural lectures in the "van Swieten hall" at the Medical University on September 22, 2015. These three LBG funded endowed professorships ensure sustainable integration of the expertise built up at the LBI-CR into the Partner universities.